Keyphrases
Lung Cancer
100%
Positron Emission Tomography-computed Tomography (PET-CT)
56%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
42%
18F-fluorothymidine
41%
18F-FDG PET-CT
40%
18F-FLT PET
40%
PET Parameters
40%
Small Cell Lung Cancer
40%
FLT PET
33%
SUVmax
25%
FDG PET-CT
24%
Definitive Radiotherapy
23%
SUVpeak
22%
Meta-analysis
20%
Additional Value
20%
Prospective Clinical Trial
20%
Academic Editor
20%
Meta-review
20%
18F-FDG Positron Emission Tomography
20%
Prognostic Value
20%
Therapy Evaluation
20%
PET Tracer
20%
F-18
20%
Fluorothymidine
20%
Early Response
20%
Diffusion Magnetic Resonance Imaging (dMRI)
20%
Cirrhosis
20%
Apologizing
20%
Central Hemodynamics
20%
Patient Assessment
20%
Inconvenience
20%
Injection Technique
20%
High Dose
19%
Dose Volume
19%
Metabolic Tumor Volume
17%
Hazard Ratio
17%
Overall Survival
15%
Response Assessment
15%
Positron Emission Tomography
14%
Circulation Time
14%
Central Circulation
14%
Treatment Planning
13%
Tumor Characteristics
13%
Clinical Trials
11%
Confidence Interval
11%
Conventionally Fractionated Radiotherapy
10%
Response Evaluation
10%
PubMed
9%
Radiation-induced Changes
8%
Progression-free Survival
8%
Medicine and Dentistry
Positron Emission Tomography
100%
Lung Cancer
80%
Fluorodeoxyglucose F 18
72%
Fluorine-18
60%
Positron Emission Tomography-Computed Tomography
45%
Small Cell Lung Cancer
40%
Neoplasm
30%
Diffusion MRI
20%
Meta-Analysis
20%
Radioactive Tracer
20%
Positron Emission Tomography
20%
Diagnosis
20%
Liver Cirrhosis
20%
Hemodynamic
20%
Hazard Ratio
19%
Overall Survival
15%
Central Blood Volume
15%
Drug Megadose
11%
Magnetic Resonance Imaging
11%
Progression Free Survival
10%
Heart Output
10%
Malignant Neoplasm
9%
Clinical Trial
7%
Lung Lesion
5%
Radiation Therapy
5%
Standardized Uptake Value
5%
Treatment Effect
5%
Treatment Planning
5%
Reproducibility
5%
Human Serum Albumin
5%
Technetium
5%
Iodine 125
5%
Blood Sampling
5%
Arterial Blood
5%
Human Serum Albumin Tc 99m
5%
